Skip to main content
SpringerLink
Log in
Book cover

PET and SPECT in Neurology pp 881–893Cite as

Single-Photon Emission Computed Tomography [Neuro-SPECT] Imaging of Brain Tumors

  • Chapter
  • First Online:

  • 2410 Accesses

Abstract

Primary brain tumors have an annual incidence rate of 7–19.1 cases per 100,000 population. Metastatic tumors to the brain are more common with more than 100,000 patients per year in the United States. Gliomas are the most common primary brain tumor. CT and MRI are necessary to characterize the tumor type, size, and extension. Nevertheless, in patients with brain lesions, it is not uncommon for CT and MRI to provide nonspecific information, even after contrast or gadolinium infusion. Imaging of intracranial space-occupying lesions by nuclear medicine techniques such as SPECT and PET have also been introduced as methods providing information about the metabolic status of various brain tumors. Although PET constitutes the most sophisticated modality of nuclear medicine imaging, SPECT has a lower cost, worldwide availability, and gained practical experience. The primary role of SPECT in brain tumor patients lies on the noninvasive assessment of tumor aggressiveness, differentiation of treatment-induced necrosis from tumor recurrence, assessment of response to treatment, and estimation of overall prognosis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Alexiou GA, Fotopoulos AD, Papadopoulos A, Kyritsis AP, Polyzoidis KS, Tsiouris S (2007) Evaluation of brain tumor recurrence by 99mTc-tetrofosmin SPECT: a prospective pilot study. Ann Nucl Med 21:293–8

    Google Scholar 

  • Alexiou GA, Tsiouris S, Goussia A, Papadopoulos A, Kyritsis AP, Polyzoidis KS, Fotopoulos AD (2008) Evaluation of glioma proliferation by 99mTc-Tetrofosmin. Neuro Oncol 10:104–5

    Google Scholar 

  • Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11

    Article  PubMed  Google Scholar 

  • Alexiou GA, Tsiouris S, Kyritsis AP, Argyropoulou MI, Voulgaris S, Fotopoulos AD (2010a) Assessment of glioma proliferation using imaging modalities. J Clin Neurosci 17:1233–1238

    Article  PubMed  Google Scholar 

  • Alexiou GA, Gogou P, Markoula S, Kyritsis AP (2010b) Management of meningiomas. Clin Neurol Neurosurg 112:177–182

    Article  PubMed  Google Scholar 

  • Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, Fotopoulos AD (2010c) The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme. J Nucl Med 51:1923–6

    Google Scholar 

  • Amin A, Moustafa H, Ahmed E, El-Toukhy M (2012) Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99 m-dimercaptosuccinic acid [Tc-99 m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results. J Neurooncol 106:579–587

    Article  CAS  PubMed  Google Scholar 

  • Barai S, Bandopadhayaya GP, Julka PK, Haloi AK, Seith A, Malhotra A (2003) Evaluation of single photon emission computerised tomography (SPECT) using Tc99m-tetrofosmin as a diagnostic modality for recurrent posterior fossa tumours. J Postgrad Med 49:316–320

    CAS  PubMed  Google Scholar 

  • Beauchesne P, Pedeux R, Boniol M, Soler C (2004) 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 3:409–413

    Google Scholar 

  • Benard F, Romsa J, Hustinx R (2002) Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33:148–162

    Article  Google Scholar 

  • Brandes AA, Franceschi E, Tosoni A et al (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192–2197

    Article  PubMed  Google Scholar 

  • Bushnell D, Menda Y, O’Dorisio T, Madsen M, Miller S, Carlisle T, Squires S, Kahn D, Walkner W, Connolly M, O’Dorisio S, Karwal M, Ponto J, Bouterfa H (2004) Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment. Cancer Biother Radiopharm 19:35–41

    Article  CAS  PubMed  Google Scholar 

  • CBTRUS (2010) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2006. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. website: www.cbtrus.org

  • Choi JY, Kim SE, Shin HJ, Kim BT, Kim JH (2000) Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose. J Neurooncol 46:63–70

    Google Scholar 

  • Coons SW, Johnson PC, Pearl DK (1994) Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. Neurosurgery 35:119–125

    Article  CAS  PubMed  Google Scholar 

  • Dammers R, Hsu SP, Krisht AF (2009) Radioguided improved resection of a cranial base meningioma. Neurosurgery 64:84–85

    Article  Google Scholar 

  • Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F (2004) Evidence that 99mTc-(V)- DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 31:77–84

    Article  CAS  PubMed  Google Scholar 

  • Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F (2005) Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 32:820–827

    Article  CAS  PubMed  Google Scholar 

  • Fotopoulos AD, Alexiou GA, Goussia A, Papadopoulos A, Kyritsis AP, Polyzoidis KS, Voulgaris S, Tsiouris S (2008) 99mTc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index. J Neurooncol 89:225–30

    Google Scholar 

  • Fotopoulos AD, Kyritsis AP, Tsiouris S, Al-Boucharali J, Papadopoulos A, Voulgaris S, Alexiou GA (2011) Characterization of intracranial space-occupying lesions by 99mTc-Tetrofosmin SPECT. J Neurooncol 101:83–9

    Google Scholar 

  • Gómez-Río M, Martínez Del Valle Torres D, Rodríguez-Fernández A, Llamas-Elvira JM, Lozano SO, Font CR, López Ramírez E, Katati M (2004) (201)Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis. Eur J Nucl Med Mol Imaging 31:1237–1243

    Article  PubMed  Google Scholar 

  • Hasegawa BH et al (2002) Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat 1:449–458

    PubMed  Google Scholar 

  • Hellwig D, Romeike BF, Ketter R, Moringlane JR, Kirsch CM, Samnick S (2008) Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas. Eur J Nucl Med Mol Imaging 35:24–31

    Article  CAS  PubMed  Google Scholar 

  • Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K (1997a) Technetium-99 m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J Nucl Med 38:1741–1749

    CAS  PubMed  Google Scholar 

  • Hirano T, Otake H, Shibasaki T, Tamura M, Endo K (1997b) Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99 m-DMSA. J Nucl Med 38:20–26

    CAS  PubMed  Google Scholar 

  • Hollingworth W, Medina LS, Lenkinski RE, ShibataDK BB, Zurakowski D, Comstock B, Jarvik JG (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. Am J Neuroradiol 27:1404–1411

    CAS  PubMed  Google Scholar 

  • Kita T, Hayashi K, Yamamoto M, Kawauchi T, Sakata I, Iwasaki Y, Kosuda S (2007) Does supplementation of contrast MR imaging with thallium-201 brain SPECT improve differentiation between benign and malignant ring-like contrast-enhanced cerebral lesions? Ann Nucl Med 21:251–256

    Article  PubMed  Google Scholar 

  • Kunishio K, Morisaki K, Matsumoto Y, Nagao S, Nishiyama Y (2003) Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas. Neurol Med Chir (Tokyo) 43:573–80

    Google Scholar 

  • Kuwert T, Probst-Cousin S, Woesler B et al (1997) Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med 38:1551–1555

    CAS  PubMed  Google Scholar 

  • Le Jeune FP, Dubois F, Blond S, Steinling M (2006a) Sestamibi technetium-99 m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 77:177–183

    Article  PubMed  Google Scholar 

  • Le Jeune N, Perek N, Dubois F (2006b) Influence of Pi3-K and PKC activity on 99mTc-(V)-DMSA uptake: correlation with tumour aggressiveness in an in vitro malignant glioblastoma cell line model. Eur J Nucl Med Mol Imaging 33:1206–1213

    Article  PubMed  Google Scholar 

  • Liu Y, Shete S, Etzel CJ et al (2010) Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 28:2467–2474

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Maillo A, Diaz P, Sayagues JM, Blanco A, Tabernero MD, Ciudad J, Lopez A, Goncalves JM, Orfao A (2001) Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer 92:377–385

    Article  CAS  PubMed  Google Scholar 

  • Matsunaga S, Shuto T, Takase H, Ohtake M, Tomura N, Tanaka T, Sonoda M (2013) Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Int J Radiat Oncol Biol Phys 85(1):47–52

    Article  PubMed  Google Scholar 

  • Minutoli F, Angileri FF, Conti A, Herberg A, Aricò D, Baldari S, Cardali S, de Divitiis O, Germanò A, Baldari S (2005) Timing of examination affects reliability of 99mTc-methoxyisobutylisonitrile SPECT in distinguishing neoplastic from nonneoplastic brain hematomas. J Nucl Med 46:574–579

    CAS  PubMed  Google Scholar 

  • Naddaf SY, Akisik MF, Aziz M, Omar WS, Hirschfeld A, Masdeu J, Donnenfeld H, Abdel-Dayem HM (1998) Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients. Nucl Med Commun 19:47–53

    Article  CAS  PubMed  Google Scholar 

  • Nathoo N, Ugokwe K, Chang AS, Li L, Ross J, Suh JH, Vogelbaum MA, Barnett GH (2007) The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas. J Neurooncol 81:167–174

    Article  PubMed  Google Scholar 

  • Oriuchi N, Tamura M, Shibazaki T et al (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34:2085–2089

    CAS  PubMed  Google Scholar 

  • Palumbo B, Lupattelli M, Pelliccioli GP, Chiarini P, Moschini TO, Palumbo I, Siepi D, Buoncristiani P, Nardi M, Giovenali P, Palumbo R (2006) Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy. Q J Nucl Med Mol Imaging 50:88–93

    CAS  PubMed  Google Scholar 

  • Park KJ, Kang SH, Park DH, Cho TH, Choe JG, Chung YG (2012) Usefulness of thallium-201 SPECT for prediction of early progression in low-grade astrocytomas diagnosed by stereotactic biopsy. Clin Neurol Neurosurg 114:223–229

    Article  PubMed  Google Scholar 

  • Perry A, Schmidt RE (2006) Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 111:197–212

    Article  CAS  PubMed  Google Scholar 

  • Plotkin M, Eisenacher J, Bruhn H, Wurm R, Michel R, Stockhammer F, Feussner A, Dudeck O, Wust P, Felix R, Amthauer H (2004) 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 70:49–58

    Article  PubMed  Google Scholar 

  • Prayson R (2005) The Utility of MIB-1/Ki-67 Immunostaining in the evaluation of Central Nervous System Neoplasms. Adv Anat Pathol 12:144–148

    Article  PubMed  Google Scholar 

  • Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, Feiden W, Kirsch CM (2002) Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 20:396–404

    Article  PubMed  Google Scholar 

  • Scott AM, Macapinlac H, Zhang JJ et al (1994) Clinical applications of fusion imaging in oncology. Nucl Med Biol 21:775–784

    Article  CAS  PubMed  Google Scholar 

  • Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, Brunon J (1998) Technetium-99 m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25:1649–1657

    Article  CAS  PubMed  Google Scholar 

  • Takeda T, Nakano T, Asano K, Shimamura N, Ohkuma H (2011) Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas. Neuroradiology 53:867–873

    Article  PubMed  Google Scholar 

  • Tsiouris S, Pirmettis I, Chatzipanagiotou T, Ptohis N, Papantoniou V (2007) Pentavalent technetium-99 m dimercaptosuccinic acid 99mTc-(V) DMSA brain scintitomography a plausible non-invasive depicter of glioblastoma proliferation and therapy response. J Neurooncol 85:291–295

    Article  CAS  PubMed  Google Scholar 

  • Vos MJ, Berkhof J, Hoekstra OS, Bosma I, Sizoo EM, Heimans JJ, Reijneveld JC, Sanchez E, Lagerwaard FJ, Buter J, Noske DP, Postma TJ (2012) MRI and thallium-201 SPECT in the prediction of survival in glioma. Neuroradiology 54:539–546

    Article  PubMed  Google Scholar 

  • Weber WA, Dick S, Reidl G et al (2001) Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 8:1144–1150

    Google Scholar 

  • Young RJ, Ghesani MV, Kagetsu NJ, Derogatis AJ (2005) Lesion size determines accuracy of thallium-201 brain single-photon emission tomography indifferentiating between intracranial malignancy and infection in AIDS patients. AJNR Am J Neuroradiol 26:1973–1979

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Ioannina Medical School, 103, Neochoropoulo, 455 00, Ioannina, Greece

    George A. Alexiou

  2. Department of Nuclear Medicine, University of Ioannina, Medical School, 103, Neochoropoulo, 455 00, Ioannina, Greece

    Spyridon Tsiouris & Andreas D. Fotopoulos

Authors
  1. George A. Alexiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Spyridon Tsiouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas D. Fotopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George A. Alexiou .

Editor information

Editors and Affiliations

  1. Dept. of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    Rudi A.J.O. Dierckx

  2. Faculty of Electrical Engineering and Information Technology, University of Applied Sciences Offenburg, Offenburg, Germany

    Andreas Otte

  3. Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands

    Erik F.J. de Vries

  4. Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands

    Aren van Waarde

  5. Neurology, University Medical Center Groningen, Groningen, The Netherlands

    Klaus L. Leenders

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Alexiou, G.A., Tsiouris, S., Fotopoulos, A.D. (2014). Single-Photon Emission Computed Tomography [Neuro-SPECT] Imaging of Brain Tumors. In: Dierckx, R., Otte, A., de Vries, E., van Waarde, A., Leenders, K. (eds) PET and SPECT in Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54307-4_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54307-4_42

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54306-7

  • Online ISBN: 978-3-642-54307-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation